LD-2 disclosure · 4th Quarter - Report
RAI SERVICES COMPANY
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesTrade (domestic/foreign)
Issues surrounding prevention of illicit tobacco, patents, tariffs, duty and customs, Free Trade Agreements (FTAs)
LobbyistsRICHARD L HASELWOOD · CARA DALMOLIN MOON · SHASHRINA THOMAS · WALKER GALLMAN
TargetedSENATE · HOUSE OF REPRESENTATIVES · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC) · U.S. International Trade Commission (ITC) · U.S. Customs & Border Protection
Tobacco
H.R. 901, Disposable ENDS Product Enforcement Act of 2023 Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA, PMTA, and MRTP compliance policies Issues surrounding tobacco harm reduction Issues surrounding efforts to prevent youth access to tobacco products Discussions in support of the regulation of products containing synthetic nicotine and disposable e-cigarettes Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 NPRM for Docket No. FDA-2021-N-1349: Tobacco Product Standard for Menthol in Cigarettes Final Rule on Premarket Tobacco Product Applications and Substantial Equivalence Marketing Authorization Pathways for New Tobacco Products Issues surrounding upcoming proposed rule on Tobacco Product Standard for Nicotine Level of Certain Tobacco Products Discussions regarding federal excise taxes and the taxation of tobacco products Discussions regarding FDA enforcement of flavored disposable e-cigarettes and PMTA transparency
LobbyistsRICHARD L HASELWOOD · CARA DALMOLIN MOON · SHASHRINA THOMAS · WALKER GALLMAN
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Office of Management & Budget (OMB) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
